Marca Nominativa depositada no INPI em 02/02/2023 por Clinipace, Inc., processo nº 501739797, nas classes 09, 10, 16, 35, 37, 38, 39, 41, 42, 44, 45. Registro em vigor até 02/02/2033.
| Número do processo | 501739797 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 02/02/2023 |
| Data da concessão | 30/07/2024 |
| Vigência até | 02/02/2033 |
| Titular | Clinipace, Inc. |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Computer software, namely, computer programs, computer program systems and program libraries, databases recorded on a data carrier in the field of pharmaceutical research and development.;
Medical apparatus, namely health monitoring equipment for clinical trials.;
Printed users manuals.;
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; business analysis, namely providing independent review of clinical trials for business purposes; contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management.;
Real estate site selection, namely, construction consultation in the course of building construction.;
Providing user access to a global computer network in connection with clinical trials and drug development; provision of access to a computer network in connection with clinical trials and drug development.;
Clinical trial logistical services such as delivering clinical trial kits to sites, delivering wearables to patients and/or site locations.;
Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; consultation in the field of publishing and issuing scientific papers in relation to conducting clinical trials, regulatory affairs, drug development, manufacturing compliance and validation, advanced technology, clinical benchmarking and clinical performance improvement in the field of international health and in the pharmaceutical, biotechnology, and medical device industries.;
Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices; software as a service (SaaS) services featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials; providing quality assurance services in the field of regulatory submissions to regulatory authorities and government agencies by life sciences companies to ensure validity and accuracy of clinical trials.;
Medical and pharmaceutical consultation.;
Legal assistance services, namely providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501739797 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.